These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 688278)

  • 1. Interstitial pulmonary fibrosis as a complication of prolonged methyl-CCNU therapy.
    Lee W; Moore RP; Wampler GL
    Cancer Treat Rep; 1978 Sep; 62(9):1355-8. PubMed ID: 688278
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulmonary fibrosis associated with low-dose adjuvant methyl-CCNU.
    Block M; Lachowiez RM; Rios C; Hirschl S
    Med Pediatr Oncol; 1990; 18(3):256-60. PubMed ID: 2329971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl-CCNU in malignant melanoma--a divided dose schedule of administration.
    Wittes RE; Hong WK; Gatchell L; Krakoff IH; Golbey RB
    Oncology; 1977; 34(1):45-6. PubMed ID: 865760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
    Creagan ET; Ahmann DL; Schutt AJ; Green SJ
    Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect.
    Boice JD; Greene MH; Killen JY; Ellenberg SS; Fraumeni JF; Keehn RJ; McFadden E; Chen TT; Stablein D
    N Engl J Med; 1986 Jan; 314(2):119-20. PubMed ID: 3941685
    [No Abstract]   [Full Text] [Related]  

  • 6. Nitrosourea-associated pulmonary fibrosis.
    Hundley RF; Lukens JN
    Cancer Treat Rep; 1979; 63(11-12):2128-30. PubMed ID: 526951
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic renal failure in children treated with methyl CCNU.
    Harmon WE; Cohen HJ; Schneeberger EE; Grupe WE
    N Engl J Med; 1979 May; 300(21):1200-3. PubMed ID: 431647
    [No Abstract]   [Full Text] [Related]  

  • 8. Nephrotoxicity of methyl-CCNU.
    Nichols WC; Moertel CG
    N Engl J Med; 1979 Nov; 301(21):1181. PubMed ID: 492286
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy.
    Micetich KC; Jensen-Akula M; Mandard JC; Fisher RI
    Am J Med; 1981 Dec; 71(6):967-72. PubMed ID: 7032289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia after therapy with methyl CCNU.
    Cohen RJ
    N Engl J Med; 1980 Jan; 302(2):120. PubMed ID: 6927914
    [No Abstract]   [Full Text] [Related]  

  • 11. Case report: acute leukemia after semustine (methyl-CCNU) therapy.
    Uphouse WJ; Oishi N
    Cancer Treat Rep; 1982 Jul; 66(7):1593-4. PubMed ID: 6953997
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute leukemia after adjuvant therapy of gastrointestinal cancer with semustine (methyl-CCNU).
    N Engl J Med; 1984 Apr; 310(16):1057-8. PubMed ID: 6708984
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicity of very high dose nitrosourea administration.
    Breeden JH; Vollmer JT; Twomey PL
    Cancer; 1982 Nov; 50(9):1728-33. PubMed ID: 7116300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected pain syndrome during a phase I study of lv methyl-CCNU.
    Haas CD; Stephens RL; Leite CJ; Goodwin JW; Hoogstraten B
    Cancer Treat Rep; 1977 Oct; 61(7):1413-5. PubMed ID: 589605
    [No Abstract]   [Full Text] [Related]  

  • 15. Methyl CCNU therapy linked leukemia.
    Shetty MR
    Cancer Chemother Pharmacol; 1981; 6(2):199. PubMed ID: 7307237
    [No Abstract]   [Full Text] [Related]  

  • 16. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.
    Diggs CH; Wiernik PH; Smyth AC
    Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea adjuvant therapy on the immune response of patients with malignant melanoma.
    Berd D; Wilson EJ; Bellet RE; Mastrangelo MJ
    Cancer Res; 1979 Nov; 39(11):4472-6. PubMed ID: 387215
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary fibrosis associated with lomustine (CCNU): a case report.
    Vats TS; Trueworthy RC; Langston CM
    Cancer Treat Rep; 1982 Oct; 66(10):1881-2. PubMed ID: 7127329
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nitrosourea-induced lung diseases].
    Massin F; Coudert B; Foucher P; Lombard JN; Reybet-Degat O; Jeannin L; Camus P
    Rev Mal Respir; 1992; 9(6):575-82. PubMed ID: 1470749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU).
    Boice JD; Greene MH; Killen JY; Ellenberg SS; Keehn RJ; McFadden E; Chen TT; Fraumeni JF
    N Engl J Med; 1983 Nov; 309(18):1079-84. PubMed ID: 6353233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.